The use of incentives to reinforce medication adherence

Preventive Medicine

Volumn 55, Issue SUPPL., 2012, Pages

  DeFulio, Anthony ^a   Silverman, Kenneth ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Applied psychology; Behavior; Behavioral economics; Behaviorism; Health behavior; Medical psychology; Medication adherence; Motivation; Patient compliance

Indexed keywords

ANTIRETROVIRUS AGENT; DISULFIRAM; ISONIAZID; NALTREXONE; NICOTINE GUM; WARFARIN;

ALCOHOLISM; DRUG DEPENDENCE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LATENT TUBERCULOSIS; OPIATE ADDICTION; PATIENT COMPLIANCE; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW;

ALCOHOLISM; EVALUATION STUDIES AS TOPIC; HEALTH BEHAVIOR; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; LATENT TUBERCULOSIS; MEDICATION ADHERENCE; MOTIVATION; REWARD; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84867234454     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.04.017     Document Type: Review

References (62)

1. American Thoracic Society Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm. Rep. 2000, 49:1-51.
2. Anderson C.A., Collier J.A. Managing very poor adherence to medication in children and adolescents: an inpatient intervention. Clin. Child Psychol. Psychiatry 1999, 4:393-402.
3. Handbook of Applied Behavior Analysis 2000, Context Press, Reno, NV. J. Austin, J.E. Carr (Eds.).
4. Baer D.M., Wolf M.M., Risley T.R. Some still-current dimensions of applied behavior analysis. J. Appl. Behav. Anal. 1987, 20:313-327.
5. Barnett P.G., Sorensen J.L., Wong W., Haug N.A., Hall S.M. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend. 2009, 100:115-121.
6. Bartlett S.J., Lukk P., Butz A., Lampros-Klein F., Rand C.S. Enhancing medication adherence among inner-city children with asthma: results from pilot studies. J. Asthma 2002, 39:47-54.
7. Carroll K.M., Ball S.A., Nich C., O'Connor, et al. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch. Gen. Psychiatry 2001, 58:755-761.
8. Carroll K.M., Sinha R., Nich C., Babuscio T., Roundsaville B.J. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp. Clin. Psychopharmacol. 2002, 10:54-63.
9. Cass A.D., Talavera G.A., Gresham L.S., Moser K.S., Joy W. Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. Int. J. Tuberc. Lung Dis. 2005, 9:415-420.
10. Chaney G., Clements B., Landau L., Bulsara M., Watt P. A new asthma spacer device to improve compliance in children: a pilot study. Respirology 2004, 9:499-506.
11. Comer S.D., Sullivan M.A., Hulse G.K. Sustained-release naltrexone: novel treatment of opioid dependence. Expert Opin. Investig. Drugs 2007, 16:1285-1294.
12. Cooper J.O., Heron T.E., Heward W.L. Applied Behavior Analysis 2007, Pearson, Upper Saddle River, NJ. second ed.
13. Cutler D.M., Everett W. Thinking outside the pillbox - medication adherence as a priority for health care reform. N. Engl. J. Med. 2010, 362:1553-1555.
14. da Costa I.G., Rapoff M.A., Lemanek K., Goldstein G.L. Improving adherence to medication regiments for children with asthma and its effect on clinical outcomes. J. Appl. Behav. Anal. 1997, 30:687-691.
15. Dapcich-Miura E., Hovell M. Contingency management of adherence to a complex medical regimen in an elderly heart patient. Behav. Ther. 1979, 10:193-201.
16. DeFulio A., Everly J.J., Leoutsakos, et al. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. Drug Alcohol Depend. 2012, 120:48-54.
17. Elk R., Grabowski J., Rhoades, et al. Compliance with tuberculosis treatment in methadone-maintained patients: behavioral interventions. J. Subst. Abuse Treat. 1993, 10:371-382.
18. Elk R., Schmitz J., Spiga R., et al. Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addict. Behav. 1995, 20:533-542.
19. Everly J.J., DeFulio A., Koffarnus M.N., et al. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial. Addiction 2011, 106:1309-1318.
20. Handbook of Applied Behavior Analysis 2011, The Guilford Press, New York. W.W. Fisher, C.C. Piazza, H.S. Roane (Eds.).
21. Grabowski J., O'Brien C.P., Greenstein R., et al. Effects of contingent payment on compliance with a naltrexone regimen. Am. J. Drug Alcohol Abuse 1979, 6:355-365.
22. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. 2008, Issue 2. Art. No. CD000011.
23. Higgins S.T., Delaney D.D., Budney A.J., et al. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
24. Contingency Management in Substance Abuse Treatment 2008, The Guilford Press, New York. S.T. Higgins, K. Silverman, S.H. Heil (Eds.).
25. Hser Y.I., Li J., Jiang H., et al. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011, 106:1801-1809.
26. Javanhakht M., Prosser P., Grimes T., Weinstein M., Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J. Int. Assoc. Physicians AIDS Car (Chic) 2006, 5:143-150.
27. Kaufman A., Baron A. Suppression of behavior by timeout punishment when suppression results in loss of positive reinforcement. J. Exp. Anal. Behav. 1968, 11:595-607.
28. Kirby K.C., Kerwin M.E., Carpenedo C.M., Rosenwasser B.J., Gardner R.S. Interdependent group contingency management for cocaine-dependent methadone maintenance patients. J. Appl. Behav. Anal. 2008, 41:579-595.
29. Koch D.A., Giardina P.J., Ryan M., MacQueen M., Hilgartner M.W. Behavioral contracting to improve adherence in patients with thalassemia. J. Pediatr. Nurs. 1993, 8:106-111.
30. Kosten T.R., Kleber H.D. Strategies to improve compliance with narcotic antagonists. Am. J. Drug Alcohol Abuse 1984, 10:249-266.
31. Kripalani S., Yao X., Haynes R.B. Interventions to enhance medication adherence in chronic medical conditions. Arch. Intern. Med. 2007, 167:540-550.
32. Laidlaw J.K., Beeken J.E., Whitney F.W., Reyes A.A. Contracting with outpatient hemodialysis patients to improve adherence to treatment. ANNA J. 1999, 26:37-40.
33. Liebson I., Bigelow G., Flamer R. Alcoholism among methadone patients: a specific treatment method. Am. J. Psychiatry 1973, 130:483-485.
34. Liebson I.A., Tommasello A., Bigelow G.E. A behavioral treatment of alcoholic methadone patients. Ann. Intern. Med. 1978, 89:342-344.
35. Lundervold D., Enterman M. Antecedent and consequent control of medical regimen adherence skills of an adult with developmental disabilities. Educ. Train. Ment. Retard. 1989, 24:126-132.
36. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
37. Martin W.P., Jasinski D.P., Mansky P.A. Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Arch. Gen. Psychiatry 1973, 28:784-791.
38. Martins N., Morris P., Kelly P.M. Food incentives to improve completion of tuberculosis treatment: randomized controlled trial in Dili, Timor-Leste. BMJ 2009, 339:b4248.
39. McDonald H.P., Garg A.X., Haynes R.B. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002, 288:2868-2879.
40. Mello N.K., Mendelson J.H., Kuehnle J.C., Sellers M.S. Operant analysis of human heroin self-administration and the effects of naltrexone. J. Pharmacol. Exp. Ther. 1981, 216:45-54.
41. Meyer R.E., Mirin S.M., Altman J.L. The clinical usefulness of narcotic antagonists: implications of behavioral research. Am. J. Drug Alcohol Abuse 1975, 2:417-432.
42. Meyer R., Randall R., Barrington C., Mirin S., Greenberg I. Limitations of an extinction approach to narcotic antagonist treatment. NIDA Res. Monogr. 1976, 9:123-135.
43. Molassiotis A., Lopez-Nahas V., Chung W.Y., Lam S.W. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care 2003, 15:125-135.
44. Mooney M., Babb D., Jensen J., Hatsukami D. Interventions to increase the use of nicotine gum: A randomized, controlled, single-blind trial. Nicotine Tob. Res. 2005, 7:565-579.
45. Morisky D.E., Malotte C.K., Ebin V., et al. Behavioral interventions for the control of tuberculosis among adolescents. Public Health Rep. 2001, 116:568-574.
46. Nunes E.V., Rothenberg J.L., Sullivan M.A., Carpenter K.M., Kleber H.D. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?. Am. J. Drug Alcohol Abuse 2006, 32:503-517.
47. Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005, 353:487-497.
48. Penica S., Williams K.E. The use of a psychological intervention to increase adherence during factor administration in a child with haemophilia. Haemophilia 2008, 14:939-944.
49. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes, and they will come: contingency management of treatment of alcohol dependence. J. Consult. Clin. Psychol. 2000, 68:250-257.
50. Pham P.A. Antiretroviral adherence and pharmacokinetics: review of their roles in sustained virologic suppression. AIDS Patient Care STDS 2009, 23:803-807.
51. Preston K.L., Silverman K., Umbricht A., DeJesus A., Montoya I.D., Schuster C.R. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 1999, 54:127-135.
52. Rapoff M.A., Purviance M.R., Lindsley C.B. Educational and behavioral strategies for improving medication compliance in juvenile rheumatoid arthritis. Arch. Phys. Med. Rehabil. 1988, 69:439-441.
53. Rigsby M.O., Rosen M.I., Beauvais J.E., et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J. Gen. Intern. Med. 2000, 15:841-847.
54. Rosen M.I., Dieckhaus K., McMahon T.J., et al. Improved adherence with contingency management. AIDS Patient Care STDS. 2007, 21:30-40.
55. Adherence to Long-Term Therapies: Evidence for Action 2003, World Health Organization, Geneva. E. Sabaté (Ed.).
56. Schecter A.J., Friedman J.G., Grossman D.J. Clinical use of naltrexone (EN-1639A): part 1: safety and efficacy in pilot studies. Am. J. Drug Alcohol Abuse 1974, 1:253-269.
57. Silverman K. Exploring the limits and utility of operant conditioning in the treatment of drug addiction. Behav. Anal. 2004, 27:209-230.
58. Sorensen J.L., Haug N.A., Delucchi K.L., et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007, 88:54-63.
59. Staring A.B.P., Van der Gaag M., Koopmans G.T., et al. Treatment adherence therapy in people with psychotic disorders: randomized controlled trial. Br. J. Psychiatry 2010, 197:448-455.
60. Tulsky J.P., Pilote L., Hahn, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch. Intern. Med. 2000, 160:697-702.
61. Volpp K.G., Loewenstein G., Troxel A.B., et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv. Res. 2008, 8:272.
62. Watt P.M., Clements B., Devadason S.G., Chaney G.M. Funhaler spacer: improving adherence without compromising delivery. Arch. Dis. Child. 2003, 88:579-581.